Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-19

Clinical Trial Update: Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial investigating silver diamine fluoride with potassium iodide for indirect pulp capping in young permanent molars; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silver Diamine Fluoride⁄Potassium Iodide (silver diamine fluoride with potassium iodide)

Snippet

Sponsor: Nourhan M.Aly | Conditions: Tertiary Dentine, Indirect Pulp Capping | Phase 2, Phase 3 | Status: COMPLETED